abiraterone
Showing 1 - 25 of 55
Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)
Not yet recruiting
- Prostate Cancer
- Docetaxel
- +2 more
-
Chicago, IllinoisNorthwestern University
Sep 27, 2023
Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)
Recruiting
- Prostate Cancer
- Prostate Cancer Metastatic
- Abivertinib
- Abiraterone
-
La Jolla, California
- +1 more
Feb 2, 2023
Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)
Enrolling by invitation
- Castration-resistant Prostate Cancer
- Polaprezinc
- Abiraterone
-
Wuxi, Jiangsu, ChinaJiangnan University
Sep 18, 2022
Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated
Recruiting
- Prostate Cancer
- +2 more
- Abiraterone
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Dec 27, 2021
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy Trial in France (Abiraterone)
Completed
- Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
- Abiraterone
-
Bordeaux, France
- +4 more
May 18, 2022
Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)
Recruiting
- Prostate Cancer
- Metastatic Prostate Cancer
- Abiraterone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Feb 21, 2023
Prostatic Tumors Trial in New York (CC-90011, Abiraterone, Prednisone)
Recruiting
- Prostatic Neoplasms
- CC-90011
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 21, 2022
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
Prostate Cancer Trial in Worldwide (Abiraterone, Apitolisib, Ipatasertib)
Completed
- Prostate Cancer
- Abiraterone
- +5 more
-
Scottsdale, Arizona
- +58 more
Sep 7, 2022
Castration-resistant Prostate Cancer Trial in Wuxi (Coenzyme A Combined With Abiraterone, Abiraterone)
Recruiting
- Castration-resistant Prostate Cancer
- Coenzyme A Combined With Abiraterone
- Abiraterone
-
Wuxi, Jiangsu, ChinaJiangnan University
Apr 8, 2021
Prostate Cancer Trial in Sao Paulo (Goserelin, Prednisone, Abiraterone)
Unknown status
- Prostate Cancer
- Goserelin
- +3 more
-
Sao Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
May 14, 2021
Prostate Cancer, Castrate Sensitive Prostate Cancer, Oligometastatic Disease Trial in Ann Arbor (drug, radiation, biological)
Recruiting
- Prostate Cancer
- +2 more
- Abiraterone
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jun 1, 2021
Prostate Cancer Trial in Boston (Abiraterone, Prednisone)
Active, not recruiting
- Prostate Cancer
- Abiraterone
- Prednisone
-
Boston, MassachusettsMassachusetts General Hospital
Feb 8, 2021
Prostate Cancer Trial in Nijmegen (abiraterone)
Completed
- Prostate Cancer
- abiraterone
-
Nijmegen, NetherlandsRadboud UMC
Dec 4, 2020
Prostate Cancer Trial in Los Angeles (TRC105, Abiraterone, Enzalutamide)
Completed
- Prostate Cancer
- TRC105
- +2 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 4, 2020
Prostatic Tumors, Castration-Resistant Trial (Abiraterone, Apalutamide)
Withdrawn
- Prostatic Neoplasms, Castration-Resistant
- Abiraterone
- Apalutamide
- (no location specified)
Nov 15, 2020